http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112142817-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 |
| filingDate | 2020-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112142817-B |
| titleOfInvention | Anti-depression steroid compound |
| abstract | The invention discloses a compound shown in a general formula I, pharmaceutically acceptable salts and solvates thereof, stereoisomers including mixtures of the compounds in various proportions, and a pharmaceutical composition containing the compound, R 1 、R 2 、R 3 、R 4a 、R 4b 、R 4c 、R 4d 、R 6a 、R 6b 、R 6c 、R 6d 、R 6e 、R 7a 、R 7b 、R 8a 、R 8b 、R 9a 、R 9b 、R 10a 、R 10b 、X 1 、X 2 、X 3 、X 4 Etc. have the meanings given in the specification. The invention also relates to a preparation method of the compounds, and also relates to applications of stereoisomers including pharmaceutically acceptable salts, solvates and mixtures in various proportions of the compounds, in particular to applications in preparing medicines for preventing, treating or relieving depression. |
| priorityDate | 2019-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 111.